No Detail Found!

Effect of taraxasterol on the expression of vegf and cxcr4 in the precancerous lesions of breast cancer in rats

Author(s)
H.M. Liu Department of Traditional Chinese Medicine, Zhongda Hospital Affiliated to Southeast University,Nanjing,China
Z.P. Wang Department of Traditional Chinese Medicine, Zhongda Hospital Affiliated to Southeast University,Nanjing,China
C.S. Wang Department of Traditional Chinese Medicine, Zhongda Hospital Affiliated to Southeast University,Nanjing,China
H. Feng Department of Traditional Chinese Medicine, Zhongda Hospital Affiliated to Southeast University,Nanjing,China
Z.G. Liu Department of Traditional Chinese Medicine, Zhongda Hospital Affiliated to Southeast University,Nanjing,China
M. Guo Department of Traditional Chinese Medicine, Zhongda Hospital Affiliated to Southeast University,Nanjing,China
Abstract
The aim of study was to explore the effect of Taraxasterol on VEGF and CXCR4 expression in the precancerous lesions of breast cancer (BC) in rats.One hundred and eighty Sprague-Dawley (SD) rats were randomly divided into control group, model group, low-dose Taraxasterol group, moderate-dose Taraxasterol group and high-dose Taraxasterol group and tamoxifen group. Dimethylbenz[a]anthracene (DMBA) was used to induce the model of dysplasia of BC in rats. After the model was successfully established, different doses of Taraxasterol were used for intervention, and tamoxifen was used as the intervention control. Finally, protein and mRNA levels of VEGF and CXCR4 were detected.The number of rats with atypical hyperplasia in high-dose Taraxasterol group and the tamoxifen group was less than that in model group (P<0.05 or P<0.01). After intervention for atypical hyperplasia rats, VEGF and CXCR4 expression levels in the Taraxasterol groups and Tamoxifen group were better than those in model group (P<0.01). In addition, VEGF and CXCR4 levels in each Taraxasterol groups differed drastically from those in the Tamoxifen group (P<0.01). The mRNA expression intensity of VEGF and CXCR4 of rats in each Taraxasterol group was superior to that of Tamoxifen group (P<0.05 or P<0.01). Taraxasterol can effectively reduce levels of VEGF and CXCR4 in DMBA-induced rat BC precancerous lesions, which may be an effective mechanism for inhibiting angiogenesis and blocking BC.
Publication Details
Page(s) 1076-1086
Published Journal: Journal of Animal and Plant sciences, Volume: 35, Issue: 4, Year: 2025

Request the full text from PASTIC

Keywords
Vascular endothelial growth factor, CXCR4, Breast cancer, Taraxasterol, Precancerous Lesions
References
Kawas Al,H. Al,I. Saaid Al,Jank P.,Westhoff C.C.,Denkert C.,Pross T.,Weiler and M.M. Karsten K.B.S. .2022 .How VEGF-A and its splice variants affect breast cancer development - clinical implications. Cell Oncol. (Dordr), 45(2) : 227-239.
Badodekar N.,Sharma A.,Patil V.,Sharma R.,Patil S.,Vyas N.,I. Somasundaram N. .2021 .Angiogenesis induction in breast cancer: a paracrine paradigm. Cell Biochem. Funct, 10(7) : 860-873.
Bao T.,Ke Y.,Wang Y.,Wang W.,Li Y.,Wang Y.,Kui X.,Zhou Q.,Zhou H.,Zhang C.,Zhou D.,Wang L.,Xiao C. .2018 .Taraxasterol suppresses the growth of human liver cancer by upregulating Hint1 expression. J. Mol. Med, 96(7) : 661-672.
Barzaman K.,Karami J.,Zarei Z.,Hosseinzadeh A.,Kazemi M.H.,Moradi-Kalbolandi S.,Safari E.,Farahmand E. .2020 .Breast cancer: biology, biomarkers, and treatments. Int. Immunopharmacol, 106535 : .
De Sousa A.M.,Dantas T.S.,Barros Silva P.G.,Martins C.D.S.,Freire G.E.,Junior H.L.R.,Brito G.A.C.,Pereira and R.F.C. Leitão K.M.A. .2021 .Analysis of the immunoexpression of Opioid Receptors and their correlation with markers of angiogenesis, cell proliferation and apoptosis in breast cancer. Asian Pac. J. Cancer Prev, 22(2) : 633-640.
Elayat G.,Selim A .2024 .Angiogenesis in breast cancer: insights and innovations. Clin. Exp. Med, 10(1) : 178.
Giri S.G.,Kim K.J.,Woo W.J.,Jung S.B.,Lee Y.M.,Lee S.J.,Jo J.H.,Kim S.C.,Park S.C. .2022 .Impact of dandelion polysaccharides on growth and immunity response in common carp Cyprinus carpio. Fish Shellfish Immunol, 08 : 371-379.
Gui H.,Fan X. .2024 .Anti-tumor effect of dandelion flavone on multiple myeloma cells and its mechanism. Discov. Oncol, 10(1) : 215.
Li Q.,Ma R.,Zhang M. .2017 .CoCl2 increases the expression of hypoxic markers HIF-1α, VEGF and CXCR4 in breast cancer MCF-7 cells. Oncol Lett, 7369(1) : 1119-1124.
Liu G.,Liu Z.,Yan Y.,Wang Y. .2017 .Effect of fraxetin on proliferation and apoptosis in breast cancer cells. Oncol. Lett, 7143(6) : 7374-7378.
Li H.,Wang P.,Gong W.,Wang Q.,Zhou J.,Zhu W. H. .2018 .Dendron-grafted polylysine-based dual-modal nanoprobe for ultra-early diagnosis of pancreatic precancerosis via targeting a Urokinase-Type Plasminogen Activator Receptor. Adv. Healthc. Mater, 10(5) : .
Li Z.,Wang Y.,Liu C.,Wang Z.,Wang D.,Liang X.,Tian X. .2021 .Association between VEGF single nucleotide polymorphism and breast cancer in the Northern China Han population. Breast Cancer Res. Treat, 10(1) : 149-156.
Mao S.,Zheng J.,Li X.,Liu Q.,Zhou J.,Cao Q.,Zhang L.,Wang C.,Qi C. .2022 .Glipizide combined with ANP Suppresses breast cancer growth and metastasis by inhibiting angiogenesis through VEGF/VEGFR2 signaling. Anticancer Agents Med Chem, 10(9) : 1735-1741.
Mishra A.,Srivastava A.,Pateriya A.,Tomar M.S.,Mishra A.K.,Shrivastava A .2021 .Metabolic reprograming confers tamoxifen resistance in breast cancer. Chem. Biol. Interact, 347 : .
Movahhed M.,Pazhouhi M.,Ghaleh H.E.G.,Kondori B.J. .2023 .Anti-metastatic effect of taraxasterol on prostate cancer cell lines. Res. Pharm. Sci, 10(4) : 378090-5362.
Qu J.,Ke F.,Yang X.,Wang Y.,Xu H.,Li Q.,Bi K. .2022 .Induction of P-glycoprotein expression by dandelion in tumor and heart tissues: impact on the anti-tumor activity and cardiotoxicity of doxorubicin. Phytomedicine, 154275 : .
Ren F.,Zhang Y.,Qin Y.,Shang J.,Wang Y.,Wei P.,Guo J.,Jia H.,Zhao T. .2022 .Taraxasterol prompted the anti-tumor effect in mice burden hepatocellular carcinoma by regulating T lymphocytes. Cell Death Discov, 8(1) : 264.
Smolanka I.I.,Bagmut I.Y.,Movchan O.V.,Sheremet M.I.,Bilyi O.M.,Lyashenko A.O.,Dosenko I.V.,Loboda A.D.,Ivankova O.M.,Kolisnyk I.L .2023 .Features of VEGF and IL-6 expression in patients with inflammatory breast cancer considering molecular-biological characteristics. J Med Life, 10(1) : 153-159.
Sohn E.J.,Jung D.B.,Lee H.,Lee J.,Lee H.,Kim S.H. .2017 .CNOT2 promotes proliferation and angiogenesis via VEGF signaling in MDA-MB-231 breast cancer cells. Cancer Lett, 09 : 88-98.
Song S.,Zeng G.,Zheng D.,Chen P.,Li M.,Yang K.,Luo J.,Yin Y.,Gu Z.,Zhang X.,Jia N.,Qiu Z.,He H.,Li H.,Liu H. .2021 .FOXO3a-driven miRNA signatures suppresses VEGF-A/NRP1 signaling and breast cancer metastasis. Oncogene, 10(4) : 777-790.
Vegunta S.,Mussallem D.M.,Kaur A.S.,Pruthi S.,Klassen C.L. .2023 .Atypical hyperplasia of the breast: clinical cases and management strategies. Cleve. Clin. J. Med, 10(7) : 22098-431.
Wang L.,Shi H.,Liu Y.,Zhang W.,Duan X.,Li M.,Shi X.,Wang T. .2019 .Cystathionine-γ-lyase promotes the metastasis of breast cancer via the VEGF signaling pathway. Int. J. Oncol, 4823(2) : 473-487.
Wang Q.,Zhang R.,He Y.,Mao G.,Kong Z. .2024 .Taraxasterol enhanced bladder cancer cells radiosensitivity via inhibiting the COX2/PGE2/JAK2/STAT3/MMP pathway. Int. J. Radiat. Biol, 2324475(5) : 791-801.
Wang F.,Li S.,Zhao Y.,Yang K.,Chen M.,Niu H.,Yang J.,Luo Y.,Tang W.,Sheng M. .2016 .Predictive role of the overexpression for CXCR4, C-Met, and VEGF-C among breast cancer patients: A meta-analysis. Breast, 04 : 45-53.
Xu C.,Zhao H.,Chen H.,Yao Q. .2015 .CXCR4 in breast cancer: oncogenic role and therapeutic targeting. Drug Des Devel Ther, 10 : 4953-64.
Xu Z.,Wang X.,Sun W.,Xu F.,Kou H.,Hu W.,Zhang Y.,Jiang Q.,Tang J.,Xu Y. .2023 .RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer. Redox Biol, 68 : .
Yang K.,Wang Y. .2024 .Dandelion root extracts and taraxasterol inhibit LPS‑ induced colorectal cancer cell viability by blocking TLR4‑ NFκB‑ driven ACE2 and TMPRSS2 pathways. Exp. Ther. Med, 12544(6) : 256.
Yang Y.,Li J.,Lei W.,Wang H.,Ni Y.,Yan H.,Tian Y.,Wang Z.,Yang Z.,Yang S.,Yang Y.,Wang Q. .2023 .CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications. Int. J. Biol. Sci, 19(11) : 3341-3359.
Zhang Z.,Song L.,Shi L.,Zhou J.,Zhang Y.,Li D.Q.,Jin Y.,Ohizumi J.,Xu Y.,Guo Y. .2021 .A dandelion polysaccharide and its selenium nanoparticles: structure features and evaluation of anti-tumor activity in zebrafish models. Carbohydr. Polym, 118365 : .
Zhou S.,Wang Z.,Hao Y.,An P.,Luo J.,Luo Y. .2023 .Dandelion polysaccharides ameliorate high-fat-diet-induced atherosclerosis in mice through antioxidant and anti-inflammatory capabilities. Nutrients, 10(19) : 4120.
Zhou Y.,Yu F.,Zhang F.,Wang K.,Sun M.,Li J.,Oupický and D. .2018 .Cyclam-Modified PEI for combined VEGF siRNA silencing and CXCR4 inhibition to treat metastatic breast cancer. Biomacromolecules, 10(2) : 392-401.
Zhu J.,Li X.,Zhang S.,Yao X.,Zhao Q.,Kou B.,Wang X.,Bai Y.,Zheng Z.,Xu C. .2021 .Taraxasterol inhibits TGF-β1-induced epithelial-to-mesenchymal transition in papillary thyroid cancer cells through regulating the Wnt/β-catenin signaling. Hum. Exp. Toxicol, 40(12) : S87-S95.
0

Citations

0

Downloads

19

Views